ConductScience.org, home

Paper41997994

Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients.

Litwin SM and 22 others. Sci Rep, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients. Papers, record 41997994. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997994

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients.
PubMed
Journal
Sci Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Litwin SMSean M
2Trinh IVIvy V
3Bai SShuangyi
4Sabino-Santos GGilberto
5Tong SSherry
6Murrell AEAmelie E
7Scott JCJordan C
8Chandra SSruti
9Elliott DHDebra H
10Smira ARAshley R
11Meyers ELErik L
12Srinivasan SShruti
13Francis MMariza
14Goff KAKelly A
15Scheuermann SESarah E
16Zwezdaryk KJKevin J
17Maness NJNicholas J
18Karger ABAmy B
19Schieffelin JSJohn S
20Gunn BMBronwyn M

Source PubMed

See all 23 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
gag Gene Products, Human Immunodeficiency VirusMajor topic
T-LymphocytesMajor topic
COVID-19 VaccinesMajor topic
Anti-Retroviral AgentsMajor topic
Humans
Female
Male
Neutralization Tests
Adult
COVID-19
Middle Aged
Antibodies, Neutralizing
HIV-1
CD4-Positive T-Lymphocytes
mRNA Vaccines
SARS-CoV-2

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P51 OD011104NIH HHSUnited StatesP51OD011104PubMedNIH RePORTER
U54CA260581-01NIH HHSUnited StatesU54CA260581PubMedNIH RePORTER

Download CSV of grants

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138423018Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+ T cell clonotypes.Cell Rep Med2024https://conductscience.org/library/papers/38423018PubMed
234193870SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.Nat Commun2021https://conductscience.org/library/papers/34193870PubMed
333322797IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients.Cells2020https://conductscience.org/library/papers/33322797PubMed
436536068Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection.Nat Rev Immunol2023https://conductscience.org/library/papers/36536068PubMed
519949327Immunization for HIV-positive individuals.Curr Opin Infect Dis2010https://conductscience.org/library/papers/19949327PubMed
633808066COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health2021https://conductscience.org/library/papers/33808066PubMed
732585083An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.Curr Protoc Microbiol2020https://conductscience.org/library/papers/32585083PubMed
837821620The immune response to SARS-CoV-2 in people with HIV.Cell Mol Immunol2024https://conductscience.org/library/papers/37821620PubMed
939223211T-cell responses to ancestral SARS-CoV-2 and Omicron variant among unvaccinated pregnant and postpartum women living with and without HIV in South Africa.Sci Rep2024https://conductscience.org/library/papers/39223211PubMed
1035561704Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19.Lancet HIV2022https://conductscience.org/library/papers/35561704PubMed
1137790941Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature.Front Immunol2023https://conductscience.org/library/papers/37790941PubMed
121358913Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients.J Clin Immunol1992https://conductscience.org/library/papers/1358913PubMed
1331470903HIV infection drives IgM and IgG3 subclass bias in Plasmodium falciparum-specific and total immunoglobulin concentration in Western Kenya.Malar J2019https://conductscience.org/library/papers/31470903PubMed
1419361304Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.Clin Infect Dis2009https://conductscience.org/library/papers/19361304PubMed
1534559854Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma.PLoS Pathog2021https://conductscience.org/library/papers/34559854PubMed
1614871298Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway.Scand J Immunol2004https://conductscience.org/library/papers/14871298PubMed
1727239760PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals.Nat Med2016https://conductscience.org/library/papers/27239760PubMed
1832979941Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.Cell2020https://conductscience.org/library/papers/32979941PubMed
1925489001Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.J Infect Dis2015https://conductscience.org/library/papers/25489001PubMed
2036560539Immune Responses against the Omicron Variant of SARS-CoV-2 after a Third Dose of COVID-19 Vaccine in Patients Living with Human Immunodeficiency Virus (PLWH): Comparison with Healthcare Workers.Vaccines (Basel)2022https://conductscience.org/library/papers/36560539PubMed

See all 92 referencesDownload CSV of references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IGHA13493PubTator's text mininghttps://conductscience.org/library/genes/3493NCBI Gene
IGHG33502PubTator's text mininghttps://conductscience.org/library/genes/3502NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41997994

GET https://conductscience.org/api/papers/v1/41997994/authors?page=2